Goldman Sachs Maintains Buy Rating on Intuitive Surgical (ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 Best Debt-Free S&P 500 Stocks to Buy Now.

On May 27, 2026, Goldman Sachs lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $558 from $621 and maintained a Buy rating on the shares. Goldman Sachs said MedTech has gone through one of its weakest periods in 15-20 years across performance, valuation, and outlook revisions, with pressure from sector rotation, slower growth, reimbursement and competitive risks, and aging investment narratives.

On May 18, 2026, BofA lowered the firm’s price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 and maintained a Buy rating on the shares. BofA said it updated several price targets after hosting 34 medtech companies in Las Vegas, citing “the new reality of medtech valuations” in a year marked by fewer product cycles, ACA and utilization worries, post-war inflation pressure, and “data centers over healthcare.”

Goldman Sachs Maintains Buy Rating on Intuitive Surgical (ISRG)

Last month, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported Q1 adjusted EPS of $2.50, ahead of the consensus estimate of $2.11. Revenue totaled $2.77B, above the consensus estimate of $2.62B. Worldwide procedures across da Vinci and Ion grew approximately 17% year-over-year, with da Vinci procedures up approximately 16% and Ion procedures up approximately 39%. The company placed 431 da Vinci surgical systems, compared with 367 in the first quarter of 2025, and placed 52 Ion endoluminal systems, compared with 49 last year.

Intuitive Surgical, Inc. (NASDAQ:ISRG) develops, manufactures, and markets products that support minimally invasive care in the United States and internationally.

While we acknowledge the risk and potential of ISRG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ISRG and that has 10,000% upside potential, check out our report about the cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1